Microfluidic Systems for Cancer Diagnosis and Applications

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Cancer Research

Background:

• Microfluidic devices enable precise manipulation of small fluid volumes, mimicking biological systems.
• Accessible production methods facilitate point-of-care diagnostics outside traditional laboratories.
• Microfluidics is expanding from general clinical applications to advanced cancer diagnostics.

Purpose of the Study:

• To review the progress of microfluidic platforms for cancer diagnostics.
• To highlight the need for sensitive detection of low-abundance cancer biomarkers in blood and serum.
• To discuss the potential of integrated microfluidic systems for multimodal cancer analysis.

Main Methods:

• Review of recent literature on microfluidic applications in cancer research.
• Analysis of microfluidic technologies for single cancer cell detection and liquid biopsy.
• Examination of microfluidic platforms for drug screening, angiogenesis, and metastasis modeling.

Main Results:

• Microfluidic tools show significant promise for detecting rare cancer cells and biomarkers.
• Integrated microfluidic platforms are being developed for comprehensive cancer diagnostics.
• These technologies offer potential for improved, personalized cancer management.

Conclusions:

• Microfluidics represents a key enabling technology for next-generation cancer diagnostics.
• Further development of integrated microfluidic platforms is crucial for clinical translation.
• Microfluidic approaches can enhance early cancer detection and treatment strategies.